- Home
- DAWN vs BMBL Comparison
DAWN vs BMBL Comparison
Compare DAWN & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- BMBL
- Stock Information
- Founded
- DAWN 2018
- BMBL 2014
- Country
- DAWN United States
- BMBL United States
- Employees
- DAWN N/A
- BMBL N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- BMBL Computer Software: Prepackaged Software
- Sector
- DAWN Health Care
- BMBL Technology
- Exchange
- DAWN Nasdaq
- BMBL Nasdaq
- Market Cap
- DAWN 624.8M
- BMBL 545.0M
- IPO Year
- DAWN 2021
- BMBL 2021
- Fundamental
- Price
- DAWN $7.47
- BMBL $5.33
- Analyst Decision
- DAWN Strong Buy
- BMBL Hold
- Analyst Count
- DAWN 7
- BMBL 14
- Target Price
- DAWN $27.86
- BMBL $6.61
- AVG Volume (30 Days)
- DAWN 1.5M
- BMBL 2.6M
- Earning Date
- DAWN 10-30-2025
- BMBL 11-05-2025
- Dividend Yield
- DAWN N/A
- BMBL N/A
- EPS Growth
- DAWN N/A
- BMBL N/A
- EPS
- DAWN N/A
- BMBL N/A
- Revenue
- DAWN $187,638,000.00
- BMBL $1,030,583,000.00
- Revenue This Year
- DAWN $12.96
- BMBL N/A
- Revenue Next Year
- DAWN $48.40
- BMBL N/A
- P/E Ratio
- DAWN N/A
- BMBL N/A
- Revenue Growth
- DAWN 2190.50
- BMBL N/A
- 52 Week Low
- DAWN $5.64
- BMBL $3.55
- 52 Week High
- DAWN $16.76
- BMBL $9.22
- Technical
- Relative Strength Index (RSI)
- DAWN 53.82
- BMBL 32.62
- Support Level
- DAWN $6.99
- BMBL $5.04
- Resistance Level
- DAWN $7.73
- BMBL $5.77
- Average True Range (ATR)
- DAWN 0.44
- BMBL 0.25
- MACD
- DAWN 0.02
- BMBL -0.06
- Stochastic Oscillator
- DAWN 48.73
- BMBL 22.39
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.